ASTAL LABORATORIES LIMITED Share Price

₹ 53.71

-₹7.99 (-12.95%)
1D
Last updated 02 Nov, 2026, 15:55 IST
BSE: 512600
|
Trading

ASTAL LABORATORIES LIMITED Share Price Today

As of 3 Nov 2026, ASTAL LABORATORIES LIMITED share price is ₹53.71. The stock opened at ₹62.90, compared to its previous close of ₹61.70. During today's trading session, ASTAL LABORATORIES LIMITED share price moved in the range of ₹52.05 to ₹62.90, with an average price of ₹57.47 for the day. Looking at its last 52-week, the stock has touched a low of ₹52.05 and a high of ₹99.95.

Share price over the last 1 day fell from 61.80 to 53.05, ranging between 52.05 and 62.90.
₹52.05
12.95% down today
₹62.90
1D LOW
1D HIGH

ASTAL LABORATORIES LIMITED Stock Insights

Latest Earning
Op Profit TrendUp by 24.10% QoQ
Latest Earning
Net Profit TrendUp by 22.66% QoQ
Latest Earning
Revenue TrendUp by 287.43% YoY
Stock Performance
OutperformingBeat Nifty by 2.61 % in last 6 month
Shareholding Pattern
PromoterPromoter increased stake by 1.28%
ASTAL LABORATORIES LIMITED stock performance
Open₹62.90
High₹62.90
Low₹52.05
Prev. close₹61.70
ASTAL LABORATORIES LIMITED trading activity
Volume1,16,752
Average traded price₹55.78
Last traded time03:55:37 02 Nov
Last traded quantity200
Circuit
L
H
₹42.97
₹64.45
52-week
L
H
₹52.05
₹99.95
Mkt Cap Cr
270.24
P/E
18.36
P/B
0.8
ROA
4.28%
ROE
4.41%
ROCE
5.15%
Quick Ratio
1.07
EV/EBITDA
10.45

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Astal Lab has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Astal Lab appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Astal Lab revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

ASTAL LABORATORIES LIMITED Company Background

ISIN
INE307N01014
Sector Market Cap
₹ 270.24 Cr

Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.

ASTAL LABORATORIES LIMITED Financial Highlights

  • Revenue: ASTAL LABORATORIES LIMITED reported revenue of ₹249.35 crore in FY26 vs ₹64.36 crore in FY25. It showed an increase of 287.43% on a yearly basis.
  • Operating Profit: ASTAL LABORATORIES LIMITED reported an operating profit of ₹17.73 crore in FY26 vs ₹11.98 crore in FY25. It showed an increase of 48.00% on a year-on-year basis.
  • Net Profit: ASTAL LABORATORIES LIMITED reported a net profit of ₹14.71 crore in FY26 vs ₹8.93 crore in FY25. It showed an increase of 64.73% on a yearly basis.

ASTAL LABORATORIES LIMITED Quarterly Result Highlights

  • ASTAL LABORATORIES LIMITED reported revenue of ₹101.08 crore in Jun 2026, compared with ₹134.15 crore in Mar 2026, representing a decrease of 24.65% on a quarter-on-quarter (QoQ) basis.
  • ASTAL LABORATORIES LIMITED reported an operating profit of ₹10.35 crore in Jun 2026, compared with ₹8.34 crore in Mar 2026, representing an increase of 24.10% on a quarter-on-quarter (QoQ) basis.
  • ASTAL LABORATORIES LIMITED reported a profit of ₹9.42 crore in Jun 2026, compared with ₹7.68 crore in Mar 2026, reflecting an increase of 22.66% on a QoQ basis.
  • The earnings per share (EPS) of ASTAL LABORATORIES LIMITED stood at ₹8.62 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
4.59%
FII
0.00%
Other DII
0.00%
Retail and other
95.41%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 20260.00%
May 20260.00%
Jun 20260.00%
Sep 20260.00%

ASTAL LABORATORIES LIMITED Investment Returns

1 day
-12.95%
1 week
-18.57%
1 month
-22.76%
1 year
-43.90%
3 years
+59.61%
5 years
+483.80%

ASTAL LABORATORIES LIMITED Share Price History

ASTAL LABORATORIES LIMITED share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹62.90 / ₹53.71
-12.95%
30 Oct 26
₹63.95 / ₹61.70
-2.17%
29 Oct 26
₹66.10 / ₹63.07
-4.35%
28 Oct 26
₹66.05 / ₹65.94
-1.36%
Show more

ASTAL LABORATORIES LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Revenue₹250.15₹64.23
Other Income₹0.22₹0.13
Total Revenue₹250.37₹64.36
Total Expenses₹232.64₹52.38
Profit Before Tax₹17.73₹11.98
Tax₹3.02₹3.05
Profit After Tax₹14.71₹8.93
EPS - Basic₹8.62₹9.08
EPS - Diluted₹7.81₹8.04

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Profit before tax₹17.73₹11.98
Income before WC changes₹20.77₹12.78
Change in Assets-₹71.99-₹23.36
Change in Liabilities₹48.67-₹1.63
Change in WC-₹23.31-₹24.99
Cash flow from Operations-₹17.70-₹12.52
Cash flow from Investing-₹2.17-₹7.81
Cash flow from Financing₹2.58₹3.29
Total Cash Flow-₹17.29-₹17.04
Cash (Start of the year)-₹10.96₹6.08
Cash (End of the year)-₹28.25-₹10.96

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Non-Current Assets₹275.59₹17.70
Current Assets₹243.16₹45.64
Total Assets₹518.74₹63.34
Current Liabilities₹164.83₹26.77
Net Current Asset₹78.32₹18.87
Non-Current Liabilities₹20.15₹0.57
Equity Capital₹333.76₹35.99
Total Equity & Liabilities₹518.74₹63.34

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹156.00₹64.23₹23.65₹3.43
Other Income₹0.19₹0.13₹0.01₹0.18
Total Revenue₹156.19₹64.36₹23.66₹3.61
Total Expenses₹145.32₹52.38₹22.57₹3.57
Profit Before Tax₹10.87₹11.98₹1.09₹0.03
Tax₹2.75₹3.05₹0.30₹0.02
Profit After Tax₹8.12₹8.93₹0.78₹0.02
EPS - Basic₹4.76₹9.08₹1.55₹0.04
EPS - Diluted₹4.31₹8.04₹1.55₹0.04

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹10.87₹11.98₹1.09₹0.03
Income before WC changes₹12.77₹12.78₹1.11-₹0.14
Change in Assets-₹58.66-₹23.36-₹14.62-₹5.95
Change in Liabilities₹43.83-₹1.63₹7.96₹4.66
Change in WC-₹14.83-₹24.99-₹6.66-₹1.29
Cash flow from Operations-₹3.08-₹12.52-₹5.58-₹1.44
Cash flow from Investing-₹1.28-₹7.81-₹6.11₹1.50
Cash flow from Financing₹4.55₹3.29₹17.68₹0.00
Total Cash Flow₹0.19-₹17.04₹5.99₹0.07
Cash (Start of the year)-₹10.96₹6.08₹0.08₹0.02
Cash (End of the year)-₹10.78-₹10.96₹6.08₹0.08

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹296.31₹17.70₹9.89₹3.79
Current Assets₹103.26₹45.64₹26.73₹6.11
Total Assets₹399.57₹63.34₹36.61₹9.91
Current Liabilities₹71.11₹26.77₹13.01₹4.73
Net Current Asset₹32.15₹18.87₹13.72₹1.38
Non-Current Liabilities₹1.29₹0.57₹0.26₹0.00
Equity Capital₹327.16₹35.99₹23.34₹5.18
Total Equity & Liabilities₹399.57₹63.34₹36.61₹9.91
* All values are in INR Crore
ASTAL LABORATORIES LIMITED market depth
Bid quantityBid priceAsk priceAsk quantity
0053.3930
0000
0000
0000
0000
Total bid quantity0
Total ask quantity30
ASTAL LABORATORIES LIMITED technical summary
Bearish indicators2
Neutral indicators3
Bullish indicators3
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
32.82
Neutral
ATR (14)
3.62
Neutral
STOCH(9,6)
14.68
Bullish
STOCH RSI (14)
7.63
Bullish
ADX(9)
29.89
Bearish
UO(9)
47.62
Neutral
ROC(12)
-6.5
Bearish
WillR(14)
-85.32
Bullish
Period
Simple value
Exponential vaue
5D
64.7
64.04
10D
65.83
65.31
20D
67.17
67.07
50D
72.41
71.16
100D
77.31
73.96
Volume trend — traded volume by day
2 Nov1L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

ASTAL LABORATORIES LIMITED
Trading
Add Stock
Add Another

ASTAL LABORATORIES LIMITED Share Price FAQs

Please be aware that ASTAL LABORATORIES LIMITED stock prices are subject to continuous fluctuations due to various factors.